Some Topical Analgesics Draw Outside US FDA’s Lines For Formulations And Indications

FDA warns six businesses found selling directly to consumers topical formulations containing lidocaine outside the 0.5% to 4% concentration range allowed under OTC monographs for topical analgesics

The Food and Drug Administration’s concerns about continued marketing of noncompliant topical analgesics get an indelible stamp of urgency as more US adults are having tattoos applied, and a higher number still will get one or more.

The FDA on 26 March announced warning letters to six businesses found selling directly to consumers topical formulations containing lidocaine...